{
    "xml": "<topic id=\"PHP1003\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/nebivolol\" basename=\"nebivolol\" title=\"NEBIVOLOL\">\n<title>NEBIVOLOL</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_883\" namespace=\"/interactions/list-of-drug-interactions/beta-blockers/nebivolol\">Nebivolol</xref>\n</p>\n<data name=\"vtmid\">318638009</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_613648210\" title=\"Beta-adrenoceptor blockers\">Beta-adrenoceptor blockers</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34515\" title=\"BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)\" namespace=\"/drug-classes/beta-adrenoceptor-blockers-systemic\">BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\r\n</body>\n<topic id=\"PHP43418\" outputclass=\"indicationsAndDose\" rev=\"1.16\" parent=\"/drugs/nebivolol\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Essential hypertension</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg daily.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Elderly</p>\n<p>Initially 2.5&#8239;mg daily, then increased if necessary to 5&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Hypertension in patient with renal impairment</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 2.5&#8239;mg once daily, then increased if necessary to 5&#8239;mg once daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Adjunct in stable mild to moderate heart failure</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult 70 years and over</p>\n<p>Initially 1.25&#8239;mg once daily for 1&#8211;2 weeks, then increased if tolerated to 2.5&#8239;mg once daily for 1&#8211;2 weeks, then increased if tolerated to 5&#8239;mg once daily for 1&#8211;2 weeks, then increased if tolerated to 10&#8239;mg once daily.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43464\" outputclass=\"contraindications\" rev=\"1.7\" parent=\"/drugs/nebivolol\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Acute or decompensated heart failure requiring intravenous inotropes</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43375\" outputclass=\"sideEffects\" rev=\"1.15\" parent=\"/drugs/nebivolol\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Depression</ph>; <ph outputclass=\"sideEffect\">oedema</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43490\" outputclass=\"breastFeeding\" parent=\"/drugs/nebivolol\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturers advise avoidance.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43432\" outputclass=\"hepaticImpairment\" parent=\"/drugs/nebivolol\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>No information available&#8212;manufacturer advises avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP43384\" outputclass=\"renalImpairment\" parent=\"/drugs/nebivolol\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid in heart failure if serum creatinine greater than 250&#8239;micromol/litre.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP1003-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/nebivolol\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75939\" title=\"Tablet\" namespace=\"/drugs/nebivolol/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78138\" namespace=\"/treatment-summaries/heart-failure\" title=\"Heart failure\" count=\"1\" rel=\"backlink\">Heart failure</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78218\" namespace=\"/treatment-summaries/beta-adrenoceptor-blocking-drugs\" title=\"Beta-adrenoceptor blocking drugs\" count=\"3\" rel=\"backlink\">Beta-adrenoceptor blocking drugs</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_883\" namespace=\"/interactions/list-of-drug-interactions/beta-blockers/nebivolol\" title=\"Nebivolol\" count=\"1\" rel=\"link\">Nebivolol</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34515\" namespace=\"/drug-classes/beta-adrenoceptor-blockers-systemic\" title=\"BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)\" count=\"1\" rel=\"link\">BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75939\" namespace=\"/drugs/nebivolol/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP1003",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/nebivolol",
    "basename": "nebivolol",
    "title": "NEBIVOLOL",
    "interactants": [
        {
            "id": "bnf_int_883",
            "label": "Nebivolol"
        }
    ],
    "vtmid": "318638009",
    "drugClassification": [
        "Beta-adrenoceptor blockers"
    ],
    "inheritsFromClass": [
        "BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Essential hypertension",
                        "html": "Essential hypertension"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "5 mg daily.",
                        "html": "<p>5&#8239;mg daily.</p>"
                    },
                    {
                        "textContent": "Initially 2.5 mg daily, then increased if necessary to 5 mg daily.",
                        "html": "<p>Initially 2.5&#8239;mg daily, then increased if necessary to 5&#8239;mg daily.</p>",
                        "ageGroup": "elderly"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Hypertension in patient with renal impairment",
                        "html": "Hypertension in patient with renal impairment"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 2.5 mg once daily, then increased if necessary to 5 mg once daily.",
                        "html": "<p>Initially 2.5&#8239;mg once daily, then increased if necessary to 5&#8239;mg once daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Adjunct in stable mild to moderate heart failure",
                        "html": "Adjunct in stable mild to moderate heart failure"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 1.25 mg once daily for 1&#8211;2 weeks, then increased if tolerated to 2.5 mg once daily for 1&#8211;2 weeks, then increased if tolerated to 5 mg once daily for 1&#8211;2 weeks, then increased if tolerated to 10 mg once daily.",
                        "html": "<p>Initially 1.25&#8239;mg once daily for 1&#8211;2 weeks, then increased if tolerated to 2.5&#8239;mg once daily for 1&#8211;2 weeks, then increased if tolerated to 5&#8239;mg once daily for 1&#8211;2 weeks, then increased if tolerated to 10&#8239;mg once daily.</p>",
                        "ageGroup": "70 years and over"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Acute or decompensated heart failure requiring intravenous inotropes",
                "html": "Acute or decompensated heart failure requiring intravenous inotropes"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Depression",
                        "html": "Depression",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "oedema",
                        "html": "oedema",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturers advise avoidance.",
                "html": "<p>Manufacturers advise avoidance.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "No information available&#8212;manufacturer advises avoid.",
                "html": "<p>No information available&#8212;manufacturer advises avoid.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid in heart failure if serum creatinine greater than 250 micromol/litre.",
                "html": "<p>Manufacturer advises avoid in heart failure if serum creatinine greater than 250&#8239;micromol/litre.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75939",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78138",
                "label": "Heart failure",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78218",
                "label": "Beta-adrenoceptor blocking drugs",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_883",
                "label": "Nebivolol",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34515",
                "label": "BETA-ADRENOCEPTOR BLOCKERS (SYSTEMIC)",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75939",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}